Literature DB >> 33357233

Potentially adaptive SARS-CoV-2 mutations discovered with novel spatiotemporal and explainable AI models.

Michael R Garvin1, Erica T Prates1, Mirko Pavicic1, Piet Jones1,2, B Kirtley Amos1,3, Armin Geiger1,2, Manesh B Shah1, Jared Streich1, Joao Gabriel Felipe Machado Gazolla1, David Kainer1, Ashley Cliff1,2, Jonathon Romero1,2, Nathan Keith4, James B Brown4, Daniel Jacobson5,6,7.   

Abstract

<span class="abstract_title">BACKGROUND: A mechanistic understanding of the emical">spread of <emical">span class="Species">SARS-CoV-2 and diligent tracking of ongoing mutagenesis are of key importance to plan robust strategies for confining its transmission. Large numbers of available sequences and their dates of transmission provide an unprecedented opportunity to analyze evolutionary adaptation in novel ways. Addition of high-resolution structural information can reveal the functional basis of these processes at the molecular level. Integrated systems biology-directed analyses of these data layers afford valuable insights to build a global understanding of the COVID-19 pandemic.
RESULTS: Here we identify globally distributed haplotypes from 15,789 SARS-CoV-2 genomes and model their success based on their duration, dispersal, and frequency in the host population. Our models identify mutations that are likely compensatory adaptive changes that allowed for rapid expansion of the virus. Functional predictions from structural analyses indicate that, contrary to previous reports, the Asp614Gly mutation in the spike glycoprotein (S) likely reduced transmission and the subsequent Pro323Leu mutation in the RNA-dependent RNA polymerase led to the precipitous spread of the virus. Our model also suggests that two mutations in the nsp13 helicase allowed for the adaptation of the virus to the Pacific Northwest of the USA. Finally, our explainable artificial intelligence algorithm identified a mutational hotspot in the sequence of S that also displays a signature of positive selection and may have implications for tissue or cell-specific expression of the virus.
CONCLUSIONS: These results provide valuable insights for the development of drugs and surveillance strategies to combat the current and future pandemics.

Entities:  

Keywords:  Adaptive mutation; COVID-19; Coronavirus; Local adaptation; Molecular evolution; SARS-CoV-2

Year:  2020        PMID: 33357233      PMCID: PMC7756312          DOI: 10.1186/s13059-020-02191-0

Source DB:  PubMed          Journal:  Genome Biol        ISSN: 1474-7596            Impact factor:   13.583


  79 in total

Review 1.  Virus-encoded proteinases and proteolytic processing in the Nidovirales.

Authors:  J Ziebuhr; E J Snijder; A E Gorbalenya
Journal:  J Gen Virol       Date:  2000-04       Impact factor: 3.891

2.  Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins.

Authors:  Erik Prentice; Josephine McAuliffe; Xiaotao Lu; Kanta Subbarao; Mark R Denison
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  [Epidemiology of hypothyroidism due to congenital malformation of the gland: athyreosis or ectopic thyroid (author's transl)].

Authors:  J Goujard; A Safar; A Rolland; J C Job
Journal:  Arch Fr Pediatr       Date:  1981-12

4.  Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.

Authors:  Kanchan Anand; John Ziebuhr; Parvesh Wadhwani; Jeroen R Mesters; Rolf Hilgenfeld
Journal:  Science       Date:  2003-05-13       Impact factor: 47.728

5.  The SR-rich motif in SARS-CoV nucleocapsid protein is important for virus replication.

Authors:  Shaun Tylor; Anton Andonov; Todd Cutts; Jingxin Cao; Elsey Grudesky; Gary Van Domselaar; Xuguang Li; Runtao He
Journal:  Can J Microbiol       Date:  2009-03       Impact factor: 2.419

6.  p53 degradation by a coronavirus papain-like protease suppresses type I interferon signaling.

Authors:  Lin Yuan; Zhongbin Chen; Shanshan Song; Shan Wang; Chunyan Tian; Guichun Xing; Xiaojuan Chen; Zhi-Xiong Xiao; Fuchu He; Lingqiang Zhang
Journal:  J Biol Chem       Date:  2014-12-10       Impact factor: 5.157

7.  Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant.

Authors:  Maria Pachetti; Bruna Marini; Francesca Benedetti; Fabiola Giudici; Elisabetta Mauro; Paola Storici; Claudio Masciovecchio; Silvia Angeletti; Massimo Ciccozzi; Robert C Gallo; Davide Zella; Rudy Ippodrino
Journal:  J Transl Med       Date:  2020-04-22       Impact factor: 5.531

8.  Membrane rearrangements mediated by coronavirus nonstructural proteins 3 and 4.

Authors:  Marne C Hagemeijer; Iryna Monastyrska; Janice Griffith; Peter van der Sluijs; Jarno Voortman; Paul M van Bergen en Henegouwen; Annelotte M Vonk; Peter J M Rottier; Fulvio Reggiori; Cornelis A M de Haan
Journal:  Virology       Date:  2014-05-13       Impact factor: 3.616

9.  Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer.

Authors:  Yujia Zhai; Fei Sun; Xuemei Li; Hai Pang; Xiaoling Xu; Mark Bartlam; Zihe Rao
Journal:  Nat Struct Mol Biol       Date:  2005-11       Impact factor: 15.369

Review 10.  Coronaviruses post-SARS: update on replication and pathogenesis.

Authors:  Stanley Perlman; Jason Netland
Journal:  Nat Rev Microbiol       Date:  2009-06       Impact factor: 60.633

View more
  24 in total

1.  Antiviral Strategies Against SARS-CoV-2: A Systems Biology Approach.

Authors:  Erica T Prates; Michael R Garvin; Piet Jones; J Izaak Miller; Kyle A Sullivan; Ashley Cliff; Joao Gabriel Felipe Machado Gazolla; Manesh B Shah; Angelica M Walker; Matthew Lane; Christopher T Rentsch; Amy Justice; Mirko Pavicic; Jonathon Romero; Daniel Jacobson
Journal:  Methods Mol Biol       Date:  2022

2.  Multiple Roles of SARS-CoV-2 N Protein Facilitated by Proteoform-Specific Interactions with RNA, Host Proteins, and Convalescent Antibodies.

Authors:  Corinne A Lutomski; Tarick J El-Baba; Jani R Bolla; Carol V Robinson
Journal:  JACS Au       Date:  2021-06-15

3.  Understanding the mutational frequency in SARS-CoV-2 proteome using structural features.

Authors:  Puneet Rawat; Divya Sharma; Medha Pandey; R Prabakaran; M Michael Gromiha
Journal:  Comput Biol Med       Date:  2022-06-07       Impact factor: 6.698

4.  Interpretable machine learning for genomics.

Authors:  David S Watson
Journal:  Hum Genet       Date:  2021-10-20       Impact factor: 5.881

5.  Evolutionary analysis and lineage designation of SARS-CoV-2 genomes.

Authors:  Xiaolu Tang; Ruochen Ying; Xinmin Yao; Guanghao Li; Changcheng Wu; Yiyuli Tang; Zhida Li; Bishan Kuang; Feng Wu; Changsheng Chi; Xiaoman Du; Yi Qin; Shenghan Gao; Songnian Hu; Juncai Ma; Tiangang Liu; Xinghuo Pang; Jianwei Wang; Guoping Zhao; Wenjie Tan; Yaping Zhang; Xuemei Lu; Jian Lu
Journal:  Sci Bull (Beijing)       Date:  2021-02-06       Impact factor: 11.780

6.  Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.

Authors:  Otun Saha; Israt Islam; Rokaiya Nurani Shatadru; Nadira Naznin Rakhi; Md Shahadat Hossain; Md Mizanur Rahaman
Journal:  Virus Genes       Date:  2021-07-12       Impact factor: 2.332

7.  Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2.

Authors:  Jingsong Zhang; Yang Zhang; Jun-Yan Kang; Shuiye Chen; Yongqun He; Benhao Han; Mo-Fang Liu; Lina Lu; Li Li; Zhigang Yi; Luonan Chen
Journal:  Cell Discov       Date:  2021-06-15       Impact factor: 10.849

8.  Mutational Asymmetries in the SARS-CoV-2 Genome May Lead to Increased Hydrophobicity of Virus Proteins.

Authors:  Roman Matyášek; Kateřina Řehůřková; Kristýna Berta Marošiová; Aleš Kovařík
Journal:  Genes (Basel)       Date:  2021-05-27       Impact factor: 4.096

9.  The First Molecular Characterization of Serbian SARS-CoV-2 Isolates From a Unique Early Second Wave in Europe.

Authors:  Danijela Miljanovic; Ognjen Milicevic; Ana Loncar; Dzihan Abazovic; Dragana Despot; Ana Banko
Journal:  Front Microbiol       Date:  2021-06-18       Impact factor: 5.640

Review 10.  SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies.

Authors:  Ahmed M Almehdi; Ghalia Khoder; Aminah S Alchakee; Azizeh T Alsayyid; Nadin H Sarg; Sameh S M Soliman
Journal:  Infection       Date:  2021-08-02       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.